Trial Profile
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, in Uninfected Adult Volunteers in Uganda.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs VRC-HIVADV014-00-VP (Primary) ; VRC-HIVDNA009-00-VP (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- 12 Mar 2012 Status of the trial is completed as reported by ClinicalTrials.gov. (Extension trial; NCT01549509)
- 12 Mar 2012 Status of the trial is completed as reported by ClinicalTrials.gov. (Extension trial; NCT01549509)
- 05 Nov 2010 New trial record.